Opko Health Net Worth

Opko Health Net Worth Breakdown

  OPK
The net worth of Opko Health is the difference between its total assets and liabilities. Opko Health's net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of Opko Health's assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. Opko Health's net worth can be used as a measure of its financial health and stability which can help investors to decide if Opko Health is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in Opko Health stock.

Opko Health Net Worth Analysis

Opko Health's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Opko Health's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Opko Health's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Opko Health's net worth analysis. One common approach is to calculate Opko Health's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Opko Health's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Opko Health's net worth. This approach calculates the present value of Opko Health's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Opko Health's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Opko Health's net worth. This involves comparing Opko Health's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Opko Health's net worth relative to its peers.

Enterprise Value

1.45 Billion

To determine if Opko Health is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Opko Health's net worth research are outlined below:
Opko Health may become a speculative penny stock
The company reported the last year's revenue of 863.5 M. Reported Net Loss for the year was (188.86 M) with profit before taxes, overhead, and interest of 214.3 M.
Opko Health has about 210.46 M in cash with (28.2 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.27.
Opko Health has a poor financial position based on the latest SEC disclosures
Roughly 54.0% of the company outstanding shares are owned by corporate insiders
Latest headline from simplywall.st: Further weakness as OPKO Health drops 4.9 percent this week, taking three-year losses to 60

Opko Health Quarterly Good Will

535.87 Million

Opko Health uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Opko Health. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Opko Health's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
22nd of February 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
22nd of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Know Opko Health's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Opko Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Opko Health backward and forwards among themselves. Opko Health's institutional investor refers to the entity that pools money to purchase Opko Health's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Dimensional Fund Advisors, Inc.2024-09-30
2.3 M
Ing Investment Management Llc2024-09-30
2.1 M
Jpmorgan Chase & Co2024-09-30
1.8 M
Assenagon Asset Management Sa2024-09-30
1.5 M
Y.d. More Investments Ltd2024-06-30
1.5 M
Norges Bank2024-06-30
1.3 M
Morgan Stanley - Brokerage Accounts2024-09-30
1.3 M
Awm Investment Company Inc2024-09-30
1.3 M
Tejara Capital Ltd2024-09-30
1.1 M
Rubric Capital Management Lp2024-09-30
48.7 M
Blackrock Inc2024-06-30
29.2 M
Note, although Opko Health's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow Opko Health's market capitalization trends

The company currently falls under 'Mid-Cap' category with a total capitalization of 1.06 B.

Market Cap

1.43 Billion

Project Opko Health's profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(0.39)(0.41)
Return On Capital Employed(0.09)(0.09)
Return On Assets(0.09)(0.10)
Return On Equity(0.14)(0.14)
The company has Net Profit Margin of (0.19) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (0.62) %, which entails that for every $100 of revenue, it lost $0.62.
When accessing Opko Health's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Opko Health's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Opko Health's profitability and make more informed investment decisions.

Evaluate Opko Health's management efficiency

Opko Health has Return on Asset of (0.0897) % which means that on every $100 spent on assets, it lost $0.0897. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.0939) %, meaning that it generated no profit with money invested by stockholders. Opko Health's management efficiency ratios could be used to measure how well Opko Health manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -0.41. The value of Return On Capital Employed is expected to slide to -0.09. At this time, Opko Health's Liabilities And Stockholders Equity is quite stable compared to the past year. Change To Liabilities is expected to grow at the current pace this year, although the value of Total Current Liabilities will most likely fall to about 103.9 M.
Last ReportedProjected for Next Year
Book Value Per Share 1.85  1.18 
Tangible Book Value Per Share(0.19)(0.18)
Enterprise Value Over EBITDA(20.85)(19.81)
Price Book Value Ratio 0.82  0.78 
Enterprise Value Multiple(20.85)(19.81)
Price Fair Value 0.82  0.78 
Enterprise Value1.4 B1.5 B
Effective leadership at Opko Health drives its competitive edge in the market. Our analysis focuses on how this translates to financial performance and stock value.
Enterprise Value Revenue
1.6431
Revenue
711.4 M
Quarterly Revenue Growth
(0.03)
Revenue Per Share
0.998
Return On Equity
(0.09)
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Opko Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Opko Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Opko Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Opko Health time-series forecasting models is one of many Opko Health's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Opko Health's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Opko Health Earnings per Share Projection vs Actual

Opko Health Corporate Executives

Elected by the shareholders, the Opko Health's board of directors comprises two types of representatives: Opko Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Opko. The board's role is to monitor Opko Health's management team and ensure that shareholders' interests are well served. Opko Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Opko Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
Adam LogalCFO, Chief Accounting Officer, Sr. VP and TreasurerProfile
When determining whether Opko Health is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Opko Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Opko Health Stock. Highlighted below are key reports to facilitate an investment decision about Opko Health Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Opko Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.
You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Opko Health. If investors know Opko will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Opko Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.191
Earnings Share
(0.19)
Revenue Per Share
0.998
Quarterly Revenue Growth
(0.03)
Return On Assets
(0.09)
The market value of Opko Health is measured differently than its book value, which is the value of Opko that is recorded on the company's balance sheet. Investors also form their own opinion of Opko Health's value that differs from its market value or its book value, called intrinsic value, which is Opko Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Opko Health's market value can be influenced by many factors that don't directly affect Opko Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Opko Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Opko Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Opko Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.